Urology Drugs Research
3 comprehensive market analysis studies and research reports on the Urology Drugs sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 48 companies, enriched with industry statistics, insights, and a lot more.
Healthcare
Categories
3 Healthcare Reports
Regions
Countries
Categories
Filters and Sort
Showing 3 of 3 results in Urology Drugs
Global Urea Cycle Disorder Market
CAGR: 3.4%
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia-Pacific
Major Players:Bausch Health, Recordati Rare Diseases, Eurocept Pharmaceuticals Holding, Acer Therapeutics, Ultragenyx Pharmaceutical
Uropathy Treatment Market
CAGR: 3.91%
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:Boston Scientific, B. Braun, Cook Group, Coloplast, Beckton Dickinson
Overactive Bladder Treatment Market
CAGR: 3.42%
Study Period: 2019 - 2030
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:Medtronic, Astellas Pharma, Macleods Pharmaceuticals, Pfizer, AbbVie Ltd.
Yay! You have seen it all
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.
